Need CEUs? 100% online & self-paced. Save $148 on the 12-CEU Bundle.
About Why Be Certified State CEU Approvals Rehab Mastery FAQ CEU Courses Get The 12-CEU Bundle Login

Nightshade Plants and Arthritis: Should PTs Care?

Aug 27, 2024

Nightshade Controversy: Implications for Rheumatoid Arthritis Management

Rheumatoid arthritis (RA) is a complex autoimmune condition often accompanied by a myriad of symptoms. While dietary interventions can significantly impact disease management, the role of nightshade plants remains a topic of debate. A recent registration of a randomized clinical trial (RCT) looking at the role of nightshade plants and inflammation in those with RA will be exciting to read once finalized. Until then, let's look at these plants, how it impacts our PT patients, and how we shouldĀ educate our clients.

Nightshades, which include tomatoes, potatoes, and peppers, have long been associated with increased inflammation. For individuals with RA, this association has raised concerns about potential exacerbation of symptoms. Part of the rationale for these plants causing inflammation is due to the solanine they contain.Ā Solanine is a glycoalkaloid, a type of chemical compound that serves as a defense mechan...

Continue Reading...
Close

Before you close this tab...

Is poor nutrition stalling your patient's recovery?

Grab The REPAIR Scale (Free PDF)—a rapid composite screening tool designed by PTs, for PTs, to connect the dots between diet, inflammation, and tissue repair.

Stop guessing why your patients aren't healing. Use this 1-minute initial evaluation tool to:

  • Spot systemic barriers to physical rehabilitation instantly.
  • Flag Ultra-Processed Foods (UPFs) driving chronic tissue inflammation.
  • Know exactly when to intervene using the built-in Clinician Scoring & Interpretation guide
Download the Free REPAIR Scale
Close

50% Complete

By downloading, you'll receive the REPAIR Scale PDF and occasional clinical nutrition updates from Dr. Wells of Nutritional Physical Therapy. Unsubscribe anytime.